IRIS
FIORE, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.425
NA - Nord America 2.430
EU - Europa 1.182
SA - Sud America 248
Continente sconosciuto - Info sul continente non disponibili 91
AF - Africa 42
OC - Oceania 10
Totale 11.428
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 6.108
US - Stati Uniti d'America 2.323
CN - Cina 664
IT - Italia 599
HK - Hong Kong 213
BR - Brasile 161
VN - Vietnam 122
DE - Germania 113
FR - Francia 110
BD - Bangladesh 109
GB - Regno Unito 108
IN - India 64
CA - Canada 47
FI - Finlandia 44
NL - Olanda 44
EE - Estonia 43
ID - Indonesia 34
AR - Argentina 31
MX - Messico 25
AT - Austria 18
ZA - Sudafrica 17
IQ - Iraq 15
EC - Ecuador 14
SE - Svezia 14
CO - Colombia 13
JP - Giappone 13
UA - Ucraina 13
ES - Italia 12
TR - Turchia 12
CZ - Repubblica Ceca 11
CL - Cile 10
RU - Federazione Russa 10
SA - Arabia Saudita 10
AU - Australia 9
RO - Romania 9
PH - Filippine 8
PK - Pakistan 8
UZ - Uzbekistan 7
VE - Venezuela 7
CR - Costa Rica 6
PL - Polonia 6
GT - Guatemala 5
JM - Giamaica 5
KZ - Kazakistan 5
MY - Malesia 5
DZ - Algeria 4
HN - Honduras 4
IL - Israele 4
LT - Lituania 4
MA - Marocco 4
MD - Moldavia 4
PE - Perù 4
PY - Paraguay 4
BE - Belgio 3
BG - Bulgaria 3
EG - Egitto 3
KE - Kenya 3
NI - Nicaragua 3
PT - Portogallo 3
TW - Taiwan 3
BB - Barbados 2
BH - Bahrain 2
CM - Camerun 2
ET - Etiopia 2
HT - Haiti 2
LB - Libano 2
LY - Libia 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GF - Guiana Francese 1
GP - Guadalupe 1
HU - Ungheria 1
IE - Irlanda 1
IS - Islanda 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
LV - Lettonia 1
ML - Mali 1
MM - Myanmar 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RE - Reunion 1
RS - Serbia 1
SL - Sierra Leone 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 11.329
Salva come PNG Salva come JPEG
Città #
San Jose 677
Singapore 471
Rome 397
Ashburn 355
Hong Kong 207
Beijing 205
Hefei 200
Council Bluffs 173
Dallas 170
Columbus 111
Lauterbourg 93
London 84
Boardman 83
Munich 68
Shanghai 67
New York 60
Phoenix 58
Los Angeles 54
Santa Clara 49
Ho Chi Minh City 45
Amsterdam 32
Hanoi 27
Helsinki 23
Milan 22
Turku 21
San Francisco 20
São Paulo 20
Chicago 14
Sona 14
Toronto 14
Washington 14
Las Vegas 13
Orem 13
Brooklyn 12
Chennai 12
Mexico City 12
Naples 12
Pune 12
Atlanta 11
Boston 10
Brno 9
Buffalo 9
Montreal 9
Seattle 9
Tokyo 9
Frankfurt am Main 8
Nuremberg 8
West Jordan 8
Guangzhou 7
Hangzhou 7
Palermo 7
Rio de Janeiro 7
Tashkent 7
Haiphong 6
Jakarta 6
Johannesburg 6
Piscataway 6
Redmond 6
Ankara 5
Baghdad 5
Buenos Aires 5
Denver 5
Guayaquil 5
Hải Dương 5
New Delhi 5
Quito 5
Rocca di Papa 5
St Louis 5
Bari 4
Cascina 4
Catania 4
Dhaka 4
Lima 4
Manchester 4
Miami 4
Pasadena 4
Philadelphia 4
San José 4
Sumaré 4
Umeå 4
Vicenza 4
Vienna 4
Warsaw 4
Aprilia 3
Bogotá 3
Bologna 3
Brasília 3
Bucharest 3
Bình Dương 3
Cagliari 3
Caracas 3
Central 3
Charlotte 3
Genoa 3
Guatemala City 3
Handan 3
Hanover 3
Houston 3
Innsbruck 3
Kuala Lumpur 3
Totale 4.250
Salva come PNG Salva come JPEG
Nome #
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 347
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer 280
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 257
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 245
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 235
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review 233
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system. 225
Clinical practice guidelines for diagnosis, treatment and follow-up of exocrine pancreatic ductal adenocarcinoma: Evidence evaluation and recommendations by the italian association of medical oncology (AIOM) 224
Exploring Deep Pathomics in Lung Cancer 224
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 222
Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy 222
Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single-center observational retrospective cohort study 222
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 221
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy 219
Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single centre retrospective analysis 214
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift 213
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. 213
Clinical results of stereotactic ablative radiotherapy in the treatment of liver metastases 210
Histologic transformation to small-cell lung cancer following gefitinib and radiotherapy in a patient with pulmonary adenocarcinoma. 207
Preventing Cardiotoxicity in Personalized Breast Irradiation 205
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 204
The role of multiparametric magnetic resonance imaging in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy 190
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 171
Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience 162
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 160
Long term results of a prospective phase 2 study on volume de-escalation in neoadjuvant chemoradiotherapy of rectal cancer 147
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 143
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies 142
A Multimodal Ensemble Driven by Multiobjective Optimisation to Predict Overall Survival in Non-Small-Cell Lung Cancer 137
Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer 136
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 135
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 135
CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis 132
Beams arrangement in non small-cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis 130
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 128
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 128
Radiation-induced pneumonitis in the era of the covid-19 pandemic: artificial intelligence for differential diagnosis 128
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 123
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: The experience of a single institution with 269 patients (STONE-01) 122
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients 119
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 115
Addressing the crisis: the looming shortage of radiation oncologists and the urgency for action 114
Different biliary microbial flora influence type of complications after pancreaticoduodenectomy: a single center retrospective analysis 112
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 111
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection 111
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 109
Chemoradiation for stage III non-small cell lung cancer 108
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). 97
Doctor-in-the-Loop: An explainable, multi-view deep learning framework for predicting pathological response in non-small cell lung cancer 96
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer 91
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases 84
Radiation treatment for adult rare cancers: Oldest and newest indication 81
Precision radiotherapy by SPECT lung functional imaging in NSCLC 74
Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer. 67
Breast CancerTrastuzumab-deruxtecan and radiotherapy: a safety sub-analysis of combart prospective cohort study 65
Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS Study 63
Protective Role of Natural Compounds under Radiation-Induced Injury 62
Pancreatic cancer care: Lighting the way with the torch of staging laparoscopy and advanced imaging 61
Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments” 60
In Reply to Riou et al 60
NeoAdjuvant chemoradiation for pancreatic cancer results of an ongoing trial 60
Empowering Hepatocellular Carcinoma Ablative Therapy: A Renaissance of Collaboration 58
MULTIMODALITY TREATMENT WITH RADIOCHEMOTHERAPY AND ERLOTINIB IN ADVANCED NSCLC (MARTE TRIAL). 58
Heterotopic hip ossification resection: monocentric experiences of associated factors, outcomes, and complications 56
Radiotherapy and vascular endothelial growth factor receptor-tyrosine kinase inhibitors in renal cancer 56
Neutrophil to lymphocyte ratio (NLR) and derived neutrophil to lymphocyte ratio (D-NLR) predict non-responders and postoperative complications in patients undergoing radical surgery after neo-adjuvant radio-chemotherapy for rectal adenocarcinoma 56
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity. 56
Prognostic Score in Radiotherapy Practice for Palliative Treatments (PROPHET) Study for Bone Metastases: An Investigation Into the Clinical Effect on Treatment Prescription 55
Combined modality therapy for thoracic and head and neck cancers: A review of updated literature based on a consensus meeting 55
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 54
Protective Effects of Grape Seed Extract on Lipopolysaccharide Exposure and Radiation-Induced Intestinal Mucosal Damage: Insights from an In Vitro Study 53
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani) 53
Evaluation of Italian radiotherapy research from 1985 to 2005: preliminary analysis 52
Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study 51
In Regard to Parikh et al 51
RADIOCHEMOTHERAPY FOR LOCALLY-ADVANCED NSCLC: WHICH IS THE BEST ASSOCIATION? FROM CHEMOTHERAPY TO BIOLOGICAL TARGET IN 5 PHASES II TRIALS 49
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer 47
Preliminary results of a phase II study of induction Folfirinox followed by chemoradiation in LAPC 47
Clinical Value of Bone Radiotherapy in a Prospective Cohort of Metastatic Breast Cancer Treated with Anti-CDK4/6 46
Induction chemotherapy with cisplatin, 5-fluorouracil, and cetuximab followed by radiotherapy and cetuximad in head and neck cancers: Preliminary results of a modern integrated approach 46
Molecularly targeted therapy and radiotherapy in the management of localized gastrointestinal stromal tumor (GIST) of the rectum: a case report 46
OA24.02 - Locally Advanced Non-Small Cell Lung Cancer: RadioTherapy with Adaptive Strategy (LARTIA Trial) 45
Neoadjuvant chemoradiation in locally advanced NSCLC: impact of histology and drugs on results. 45
PV-0276 Adaptive radiotherapy: rate of "marginal" failure after "replanning" in combined treatment of NSCLC. 45
SBRT: A viable option for treating adrenal gland metastases 44
Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives 43
PAIDEIA: pacemaker and implanted cardioverter defibrillator management in radiation therapy—a survey by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 43
PATTERN OF FAILURE AFTER ADAPTIVE RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LA-NSCLC). 43
Safety and efficacy of combined radiotherapy, immunotherapy and targeted agents in elderly patients: A literature review 42
Radiomics-based prediction of overall survival in lung cancer using different volumes-of-interest 42
Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case-control study (PAULA-1) 41
Role of induction therapy in esophageal cancer 41
¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients 41
Whole-Breast Irradiation: A Subgroup Analysis of Criteria to Stratify for Prone Position Treatment 41
Comparative Effectiveness of Chemotherapy Alone Versus Radiotherapy-Based Regimens in Locally Advanced Pancreatic Cancer: A Real-World Multicenter Analysis (PAULA-1) 40
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1 40
Erlotinib and concurrent chemoradiation in pretreated NSCLC patients: radiobiological basis and clinical results. 39
Somatostatin analogs and disease control in castration-resistant prostate cancer: different biological behavior? Case series and review of the literature 39
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 38
Stereotactic body radiation therapy for early stage NSCLC: clinical outcomes 38
Totale 11.146
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.843
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.843
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022116 0 0 2 4 1 3 5 3 13 1 0 84
2022/202379 0 1 2 3 6 1 22 6 7 0 22 9
2023/2024306 11 26 19 15 27 118 14 20 3 17 12 24
2024/20256.558 46 24 146 68 60 116 71 32 279 425 2.420 2.871
2025/20263.837 310 204 233 332 206 223 1.121 206 298 327 201 176
2026/2027531 70 385 76 0 0 0 0 0 0 0 0 0
Totale 11.428